Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.
Author(s) -
HansGeorg Kräusslich,
Richard H. Ingraham,
M. T. SKOOG,
Eckard Wimmer,
Peter V. Pallai,
C A Carter
Publication year - 1989
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.86.3.807
Subject(s) - polyproteins , pepstatin , cleavage (geology) , biochemistry , proteinase 3 , enzyme , capsid , retrovirus , biology , peptide , microbiology and biotechnology , peptide sequence , chemistry , protease , antibody , gene , paleontology , fracture (geology) , immunology , autoantibody
Retroviral capsid proteins and replication enzymes are synthesized as polyproteins that are proteolytically processed to the mature products by a virus-encoded proteinase. We have purified the proteinase of human immunodeficiency virus (HIV), expressed in Escherichia coli, to approximately 90% purity. The purified enzyme at a concentration of approximately 20 nM gave rapid, efficient, and specific cleavage of an in vitro synthesized gag precursor protein. Purified HIV proteinase also induced specific cleavage of five decapeptide substrates whose amino acid sequences corresponded to cleavage sites in the HIV polyprotein but not of a peptide corresponding to a cleavage site in another retrovirus. Competition experiments with different peptides allowed a ranking of cleavage sites. Inhibition studies indicated that the HIV proteinase was inhibited by pepstatin A with an IC50 of 0.7 microM.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom